- UID
- 10003206
- 热情
- 49
- 人气
- 153
- 主题
- 25
- 帖子
- 125
- 精华
- 0
- 积分
- 178
- 分享
- 0
- 记录
- 0
- 相册
- 0
- 好友
- 0
- 日志
- 0
- 在线时间
- 159 小时
- 注册时间
- 2015-8-25
- 阅读权限
- 20
- 最后登录
- 2021-6-20
升级 78% - UID
- 10003206
- 热情
- 49
- 人气
- 153
- 主题
- 25
- 帖子
- 125
- 精华
- 0
- 积分
- 178
- 阅读权限
- 20
- 注册时间
- 2015-8-25
|
https://seekingalpha.com/news/3671724-several-european-countries-suspend-astrazeneca-covid-19-vaccine-use-over-blood-clot-concern
Several European countries suspend AstraZeneca vaccine use over blood clot concerns
Mar. 11, 2021 9:27 AM
- Health authorities in Denmark, Norway, and Iceland have suspended the use of AstraZeneca's (NASDAQ:AZN) COVID-19 vaccine amid reports of blood clots in people after receiving the shot.
- According to a statement from the Danish Health Authority, the European Medicines Agency (NYSEMKT:EMA) is investigating "reports of severe cases of blood clots," with the authority adding there was one death in Denmark in a patient following inoculation with AstraZeneca's vaccine.
- However, the authority notes it is too early to tell if there is a connection between the AstraZeneca vaccine and the cases of blood clots.
- Shortly after Denmark's announcement, health authorities in Norway and Iceland said they would also suspend inoculations of AstraZeneca's vaccine, Deutsche Welle reported.
- The actions from the three countries follows the same move from Austria after a death from multiple thrombosis 10 days after vaccination and a case of pulmonary embolism following vaccination there, according to DW.
- The EMA said yesterday that a preliminary investigation found there was "no indication" the vaccine caused these events in Austria.
- Estonia, Latvia, Lithuania, Luxembourg have also suspended use of the AstraZeneca shot, according to DW.
- AstraZeneca shares are down 1.6% to $49.01 in premarket trading.
|
|